Adlai Nortye Group Ltd.
ANL · XNASCIK 1944552fmd_0Z3A41JTQTGEM3FX7RV5G475QYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Dec 31, 2024, 4 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Total revenues | 46 | – | 5 | – |
| Research and development | 42 | 54 | 58 | 45 |
| Operating income | (9) | (67) | (73) | (53) |
| Interest expense | 1 | 0 | 1 | 2 |
| Income before taxes | (57) | (59) | (109) | (52) |
| Income tax expense | – | – | 1 | – |
| Net income from continuing operations | – | – | (110) | – |
| Net income | (57) | (59) | (109) | (52) |